scholarly journals Lung Microbiome in Asthma: Current Perspectives

2019 ◽  
Vol 8 (11) ◽  
pp. 1967 ◽  
Author(s):  
Konstantinos Loverdos ◽  
Georgios Bellos ◽  
Louiza Kokolatou ◽  
Ioannis Vasileiadis ◽  
Evangelos Giamarellos ◽  
...  
Keyword(s):  
Respiratory Diseases ◽  
Human Microbiome ◽  
Current Evidence ◽  
Host Immune System ◽  
Prevention Strategies ◽  
Chronic Respiratory Diseases ◽  
Lung Microbiome ◽  
Modes Of Interaction ◽  
Review Current

A growing body of evidence implicates the human microbiome as a potentially influential player actively engaged in shaping the pathogenetic processes underlying the endotypes and phenotypes of chronic respiratory diseases, particularly of the airways. In this article, we specifically review current evidence on the characteristics of lung microbiome, and specifically the bacteriome, the modes of interaction between lung microbiota and host immune system, the role of the “lung–gut axis”, and the functional effects thereof on asthma pathogenesis. We also attempt to explore the possibilities of therapeutic manipulation of the microbiome, aiming at the establishment of asthma prevention strategies and the optimization of asthma treatment.

scholarly journals Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease

2020 ◽  
pp. 1902320 ◽  
Author(s):  
Reinoud Gosens ◽  
Pieter S. Hiemstra ◽  
Ian M. Adcock ◽  
Ken R. Bracke ◽  
Robert P. Dickson ◽  
...  
Keyword(s):  
Microbial Community ◽  
Cross Talk ◽  
Respiratory Diseases ◽  
Human Microbiome ◽  
Targeted Therapeutics ◽  
Foreseeable Future ◽  
Prevention Strategies ◽  
Therapeutic Approaches ◽  
Chronic Respiratory Diseases ◽  
Holistic Approaches

Chronic respiratory diseases are highly prevalent worldwide and will continue to rise in the foreseeable future. Despite intensive efforts over the recent decades, the development of novel and effective therapeutic approaches has been slow. There is however new and increasing evidence that communities of microorganisms in our body, the human microbiome, are crucially involved in the development and progression of chronic respiratory diseases. Understanding the detailed mechanisms underlying this cross-talk between host and microbiota is critical for development of microbiome- or host-targeted therapeutics and prevention strategies. Here we review and discuss the most recent knowledge on the continuous reciprocal interaction between the host and microbes in health and respiratory disease. Furthermore, we highlight promising developments in microbiome-based therapies and discuss the need to employ more holistic approaches of restoring both the pulmonary niche and the microbial community.

scholarly journals Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19

2021 ◽  
Vol 10 ◽  
Author(s):  
Elisavet Stavropoulou ◽  
Konstantia Kantartzi ◽  
Christina Tsigalou ◽  
Theocharis Konstantinidis ◽  
Chrissoula Voidarou ◽  
...  
Keyword(s):  
Respiratory Diseases ◽  
Review Paper ◽  
Human Microbiome ◽  
Scientific Data ◽  
New Developments ◽  
Lung Microbiome ◽  
Intestinal Dysbiosis ◽  
Shed Light ◽  
Lung Immunity

Albeit the lungs were thought to be sterile, recent scientific data reported a microbial microbiota in the lungs of healthy individuals. Apparently, new developments in technological approachesincluding genome sequencing methodologies contributed in the identification of the microbiota and shed light on the role of the gut and lung microbiomes in the development of respiratory diseases. Moreover, knowledge of the human microbiome in health may act as a tool for evaluating characteristic shifts in the case of disease. This review paper discusses the development of respiratory disease linked to the intestinal dysbiosis which influences the lung immunity and microbiome. The gastrointestinal–lung dialogue provides interesting aspects in the pathogenesis of the respiratory diseases. Lastly, we were further interested on the role of this interconnection in the progression and physiopathology of newly emergedCOVID-19.

Role of Vasavaleha in the management of Covid19

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 259-261
Author(s):  
Aamir Khan ◽  
Rajni K. Gurmule
Keyword(s):  
Immune System ◽  
Human Body ◽  
Respiratory Diseases ◽  
Spreading Rate ◽  
Host Immune System ◽  
Shortness Of Breath ◽  
Antitussive Effect ◽  
Corona Viruses ◽  
Very High

Vasavaleha is one of the best medicine given for respiratory diseases. Corona viruses typically affect the respiratory system, causing symptoms such as coughing, fever and shortness of breath. It also affects host immune system of human body. Spreading rate of this disease is very high. Whole world is seeking for the treatment which can uproots this diseases. There in no vaccine available till date against this pandemic disease. Ayurveda mainly focuses on prevention of diseases alongwith its total cure. Rajyakshma Vyadhi is MadhyamMarga Roga as per Ayurveda. It shows many symptoms such as Kasa, Shwasa etc. By overall view of Covid 19, shows its resemblance with Rajyakshma Vyadhi described in Ayurveda. Vasavaleha is a Kalpa which is described in Rogadhikara of Rajyakshma. It shows Kasahara, Shwashara properties. It consists of Vasa, Pipalli, Madhu and Goghrita. These components shows actions like bronchodilation, antitussive effect and many more other actions. Pipalli shows important Rasayana effect. So in present review, we have tried to focus on role of Vasavaleha in the management of Covid 19. This can be used as preventive as well as adjuvant medication in treating Covid 19. There is need of further clinical research to rule of exact action of Vasavaleha against Covid 19.

From Genesis To Revelation: The Role Of Inflammatory Mediators In Chronic Respiratory Diseases And Their Control By Nucleic Acid-Based Drugs

2016 ◽  
Vol 13 (999) ◽  
pp. 1-1 ◽  
Author(s):  
Sante Di Gioia ◽  
Carla Sardo ◽  
Stefano Castellani ◽  
Barbara Porsio ◽  
Giuliana Belgiovine ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
Inflammatory Mediators ◽  
Respiratory Diseases ◽  
Chronic Respiratory Diseases

MicroRNA: Potential biomarker and target of therapy in acute lung injury

2020 ◽  
Vol 39 (11) ◽  
pp. 1429-1442
Author(s):  
Z-F Jiang ◽  
L Zhang ◽  
J Shen
Keyword(s):  
Acute Lung Injury ◽  
Lung Injury ◽  
Respiratory Diseases ◽  
Current Evidence ◽  
Biological Processes ◽  
Fatal Disease ◽  
Small Noncoding Rnas ◽  
Potential Biomarker ◽  
Indirect Injury

MicroRNAs (miRNAs) are small noncoding RNAs stretching over 18–22 nucleotides and considered to be modifiers of many respiratory diseases. They are highly evolutionary conserved and have been implicated in several biological processes, including cell proliferation, apoptosis, differentiation, among others. Acute lung injury (ALI) is a fatal disease commonly caused by direct or indirect injury factors and has a high mortality rate in intensive care unit. Changes in expression of several types of miRNAs have been reported in patients with ALI. Some miRNAs suppress cellular injury and accelerate the recovery of ALI by targeting specific molecules and decreasing excessive immune response. For this reason, miRNAs are proposed as potential biomarkers for ALI and as therapeutic targets for this disease. This review summarizes current evidence supporting the role of miRNAs in ALI.

scholarly journals IL-33 Mediated Inflammation in Chronic Respiratory Diseases—Understanding the Role of the Member of IL-1 Superfamily

2019 ◽  
Vol 10 ◽  
Author(s):  
Agata Gabryelska ◽  
Piotr Kuna ◽  
Adam Antczak ◽  
Piotr Białasiewicz ◽  
Michał Panek
Keyword(s):  
Respiratory Diseases ◽  
Chronic Respiratory Diseases

scholarly journals A roadmap to target interleukin-6 in osteoarthritis

Rheumatology ◽  
2020 ◽  
Vol 59 (10) ◽  
pp. 2681-2694
Author(s):  
Renske Wiegertjes ◽  
Fons A J van de Loo ◽  
Esmeralda N Blaney Davidson
Keyword(s):  
Synovial Fluid ◽  
Disease Incidence ◽  
Joint Inflammation ◽  
Protective Role ◽  
Future Perspective ◽  
Current Evidence ◽  
Joint Pathology ◽  
Matrix Degrading Enzymes ◽  
Review Current

Abstract Joint inflammation is present in the majority of OA patients and pro-inflammatory mediators, such as IL-6, are actively involved in disease progression. Increased levels of IL-6 in serum or synovial fluid from OA patients correlate with disease incidence and severity, with IL-6 playing a pivotal role in the development of cartilage pathology, e.g. via induction of matrix-degrading enzymes. However, IL-6 also increases expression of anti-catabolic factors, suggesting a protective role. Until now, this dual role of IL-6 is incompletely understood and may be caused by differential effects of IL-6 classic vs trans-signalling. Here, we review current evidence regarding the role of IL-6 classic- and trans-signalling in local joint pathology of cartilage, synovium and bone. Furthermore, we discuss targeting of IL-6 in experimental OA models and provide future perspective for OA treatment by evaluating currently available IL-6 targeting strategies.

scholarly journals ASSESSMENT OF MORBIDITY AND EFFECTIVENESS OF MEDICAL REHABILITATION OF CHILDREN WITH CHRONIC DISEASES OF THE RESPIRATORY SYSTEM IN CLINIC

2018 ◽  
Vol 24 (6) ◽  
pp. 284-288
Author(s):  
Viktoria V. Polunina ◽  
M. I Dubrovskaya ◽  
A. N Lobov ◽  
V. P Plotnikov ◽  
S. V Pavlova
Keyword(s):  
Chronic Diseases ◽  
Respiratory System ◽  
Respiratory Diseases ◽  
Total Duration ◽  
Average Frequency ◽  
Main Group ◽  
Medical Rehabilitation ◽  
Chronic Respiratory Diseases ◽  
Chronic Morbidity

The data obtained in the study of incidence in children, reflect the results of the children’s clinic. Analysis of the incidence was carried out according to the analysis of medical records. In the structure of general and chronic morbidity in children, the leading places belong to respiratory diseases, among which chronic diseases of adenoids and tonsils prevail (67.7%). Therefore, prevention and timely effective treatment of diseases of the respiratory system will reduce the overall incidence, and, consequently, improve the performance of a children’s clinic. To determine the role of medical rehabilitation, a group of children aged 3 to 14 years with chronic respiratory diseases was recruited in the amount of 127 children (68 boys and 59 girls). In the main group (n=78), treatment without exacerbation included 3 courses of comprehensive medical rehabilitation, including physiotherapy, reflexology, and physical therapy; in the control (n=49) treatment was carried out only in the period of exacerbation. The total duration of observation in both groups was 12 months. The effectiveness of treatment was assessed by the dynamics of the frequency and duration of colds and exacerbations of chronic diseases during the year. In the main group, the average frequency of colds for the year decreased by 2 times (p

Sign in / Sign up

Export Citation Format

Share Document